Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Intramuscular bone induction by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft.

Chen WJ, Jingushi S, Hirata G, Matsumoto Y, Iwamoto Y.

Tissue Eng. 2004 Nov-Dec;10(11-12):1652-61.

PMID:
15684674
2.
3.
4.
5.

Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.

Liang G, Yang Y, Oh S, Ong JL, Zheng C, Ran J, Yin G, Zhou D.

Biomaterials. 2005 Jul;26(20):4265-71.

PMID:
15683650
6.
7.

Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.

Tanaka E, Ishino Y, Sasaki A, Hasegawa T, Watanabe M, Dalla-Bona DA, Yamano E, van Eijden TM, Tanne K.

Ann Biomed Eng. 2006 May;34(5):717-25. Epub 2006 Mar 28.

PMID:
16568346
8.

The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.

Hong SJ, Kim CS, Han DK, Cho IH, Jung UW, Choi SH, Kim CK, Cho KS.

Biomaterials. 2006 Jul;27(20):3810-6. Epub 2006 Mar 29.

PMID:
16574220
9.

Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.

Pang EK, Im SU, Kim CS, Choi SH, Chai JK, Kim CK, Han SB, Cho KS.

J Periodontol. 2004 Oct;75(10):1364-70.

PMID:
15562914
10.

Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.

Jung RE, Weber FE, Thoma DS, Ehrbar M, Cochran DL, Hämmerle CH.

Clin Oral Implants Res. 2008 Feb;19(2):188-95. Epub 2007 Dec 6.

PMID:
18067602
11.

Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material.

Schwartz Z, Somers A, Mellonig JT, Carnes DL Jr, Wozney JM, Dean DD, Cochran DL, Boyan BD.

J Periodontol. 1998 Dec;69(12):1337-45.

PMID:
9926763
12.

The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.

E LL, Xu LL, Wu X, Wang DS, Lv Y, Wang JZ, Liu HC.

Tissue Eng Part A. 2010 Sep;16(9):2927-40. doi: 10.1089/ten.TEA.2010.0018.

PMID:
20486786
13.

[Osteogenic potential of three kinds of calcium phosphate ceramics as carriers for recombinant human morphogenetic protein-2 in vivo].

Long HQ, Li FB, Wang YJ, Liao WM, Wang HX.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2003 May;17(3):180-4. Chinese.

PMID:
12822344
14.
15.

Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration.

Lee JH, Ryu MY, Baek HR, Lee KM, Seo JH, Lee HK, Ryu HS.

J Mater Sci Mater Med. 2013 Sep;24(9):2117-27. doi: 10.1007/s10856-013-4967-5. Epub 2013 Jun 1.

PMID:
23728522
17.

Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2.

Ohura K, Hamanishi C, Tanaka S, Matsuda N.

J Biomed Mater Res. 1999 Feb;44(2):168-75.

PMID:
10397918
18.

Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.

Namikawa T, Terai H, Suzuki E, Hoshino M, Toyoda H, Nakamura H, Miyamoto S, Takahashi N, Ninomiya T, Takaoka K.

Spine (Phila Pa 1976). 2005 Aug 1;30(15):1717-22.

PMID:
16094272
19.
20.

Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.

Kim SJ, Kim MR, Oh JS, Han I, Shin SW.

Yonsei Med J. 2009 Dec 31;50(6):825-31. doi: 10.3349/ymj.2009.50.6.825. Epub 2009 Dec 18.

Items per page

Supplemental Content

Write to the Help Desk